VYNE Therapeutics Inc. - COM (VYNE)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
11
Total Shares
1.07M
Shares change
-1.63K
Total reported value, excl. options
$2.02M
Value change
-$3.46K
Put/Call ratio
0
Number of buys
3
Number of sells
-3
Price
$1.88
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.